Last reviewed · How we verify

NCT06948708

Predictive Role of HRV for PONV in Laparoscopic Cholecystectomy

Completed Last updated 16 September 2025
What this trial tests

trial in Postoperative Nausea and Vomiting (PONV) in 110 participants. Completed in 15 September 2025.

Timeline
2 May 2025
Primary endpoint
15 September 2025
15 September 2025

Quick facts

Lead sponsorKonya City Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment110
Start date2 May 2025
Primary completion15 September 2025
Estimated completion15 September 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Konya City Hospital

Who can join

Adults 18 to 65, female only, with Postoperative Nausea and Vomiting (PONV) or Heart Rate Variability (HRV). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative nausea and vomiting (PONV) are among the most common complications following general anesthesia (GA), significantly affecting patient comfort and recovery. Although various risk factors for PONV have been identified-such as female sex, non-smoking status, and history of motion sickness-these predictors are not always sufficient to determine individual risk accurately. Heart rate variability (HRV) reflects autonomic nervous system (ANS) balance and has been proposed as a potential physiological biomarker for predicting PONV. Reduced HRV is associated with increased vagal imbalance, which may contribute to gastrointestinal (GI) dysregulation and PONV. This prospective observational study aims to investigate the predictive value of HRV in estimating the incidence and severity of PONV in female patients undergoing elective laparoscopic cholecystectomy (LC). A total of 110 participants will be enrolled, and preoperative and early postoperative HRV measurements will be obtained using a validated chest-strap heart rate monitor (Polar H10). HRV parameters, including the standard deviation of normal-to-normal intervals (SDNN), the root mean square of successive differences (RMSSD), and the low-frequency/high-frequency (LF/HF) ratio, will be analyzed via the Elite HRV application. Standardized anesthesia, analgesia, and antiemetic protocols will be used for all participants. PONV severity will be assessed over the first 24 hours postoperatively using a 4-point scale. The primary objective is to evaluate whether preoperative HRV can predict PONV occurrence. Secondary outcomes include correlations between HRV parameters and PONV severity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Postoperative Nausea and Vomiting (PONV)

Currently open trials in the same condition.

Other Konya City Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06948708.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing